PCN34 PHARMAECONOMIC EVALUATION OF THE USE OF ERLOTINIB IN NON-SMALL CELLS LUNG CANCER (NSCLC) WITH FAILURE TO PREVIOUS CHEMOTHERAPY
C Tenorio, J Vargas, MI Pacheco, L González-MichacaVolume:
11
Year:
2008
Language:
english
DOI:
10.1016/s1098-3015(10)66571-0
File:
PDF, 77 KB
english, 2008